(Q36745654)

16 August 2017

1 reference

title

Nitric oxide-dependent endothelial function and cardiovascular disease (English)

1 reference

16 August 2017

0 references

cardiovascular disease

1 reference

F Desjardins

1

1 reference

16 August 2017

J L Balligand

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

1 November 2006

1 reference

16 August 2017

1 reference

16 August 2017

volume

61

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

326-334

1 reference

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Endothelial function and nitric oxide: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Nitric oxide and cardiac function: ten years after, and continuing

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Caveolins and the regulation of endothelial nitric oxide synthase in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Endothelial function: cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2006.052

21 January 2018

Identifiers

DOI

10.1179/ACB.2006.052

1 reference

16 August 2017

1 reference